Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 13, 2016 - Issue 3
Submit an article Journal homepage
742
Views
36
CrossRef citations to date
0
Altmetric
Reviews

Antibody-mediated delivery of therapeutics for cancer therapy

Sagun ParakhTumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia;Department of Medical Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Melbourne, Australia;School of Cancer Medicine, La Trobe University, Melbourne, Australia
,
Adam C. ParslowTumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia;School of Cancer Medicine, La Trobe University, Melbourne, Australia
,
Hui K. GanTumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia;Department of Medical Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Melbourne, Australia;School of Cancer Medicine, La Trobe University, Melbourne, Australia
&
Andrew M. ScottTumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia;School of Cancer Medicine, La Trobe University, Melbourne, Australia;Departmentof Molecular Imaging and Therapy, Austin Health, Melbourne, Australia;Department of Medicine, University of Melbourne, Melbourne, AustraliaCorrespondence[email protected]
Pages 401-419 | Received 10 Sep 2015, Accepted 23 Nov 2015, Published online: 19 Dec 2015

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yanan Cui, Ping Cui, Binlong Chen, Suxin Li & Hua Guan. (2017) Monoclonal antibodies: formulations of marketed products and recent advances in novel delivery system. Drug Development and Industrial Pharmacy 43:4, pages 519-530.
Read now

Articles from other publishers (35)

Seyed Hossein Abtahi Eivary, Ramiar Kamal Kheder, Soran K. Najmaldin, Nahid Kheradmand, Seyed-Alireza Esmaeili & Jafar Hajavi. (2023) Implications of IL-21 in solid tumor therapy. Medical Oncology 40:7.
Crossref
Payal Aggarwal, Wen Luo, Katherine C. Pehlivan, Hai Hoang, Prajwal Rajappa, Timothy P. Cripe, Kevin A. Cassady, Dean A. Lee & Mitchell S. Cairo. (2022) Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations. Frontiers in Immunology 13.
Crossref
Joshua Tobias, Mirjana Drinić, Anna Schmid, Anastasiya Hladik, Martin L. Watzenböck, Claire Battin, Erika Garner-Spitzer, Peter Steinberger, Michael Kundi, Sylvia Knapp, Christoph C. Zielinski & Ursula Wiedermann. (2022) Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers 14:22, pages 5678.
Crossref
Haibo Wang, Yu He, Meiling Jian, Xingang Fu, Yuheng Cheng, Yujia He, Jun Fang, Lin Li & Dan Zhang. (2022) Breaking the Bottleneck in Anticancer Drug Development: Efficient Utilization of Synthetic Biology. Molecules 27:21, pages 7480.
Crossref
Javad Garousi, Tianqi Xu, Yongsheng Liu, Olga Vorontsova, Sophia Hober, Anna Orlova, Vladimir Tolmachev, Torbjörn Gräslund & Anzhelika Vorobyeva. (2022) Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart. Pharmaceutics 14:8, pages 1612.
Crossref
Quanyuan Wan, Zihua Zeng, Jianjun Qi, Yingxin Zhao, Xiaohui Liu, Zhenghu Chen, Haijun Zhou & Youli Zu. (2022) Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c. Cancers 14:6, pages 1570.
Crossref
Sagun Parakh, Sze Ting Lee, Hui K. Gan & Andrew M. Scott. (2022) Radiolabeled Antibodies for Cancer Imaging and Therapy. Cancers 14:6, pages 1454.
Crossref
Myung-Hoon Han & Choong Hyun Kim. (2022) Current Immunotherapeutic Approaches for Malignant Gliomas. Brain Tumor Research and Treatment 10:1, pages 1.
Crossref
Sailendra Kumar Mahanta & Manoranjan Arakha. 2022. Bio-Nano Interface. Bio-Nano Interface 127 142 .
Alexander E. Braley & Walter A. Hall. 2022.
Sagun Parakh, Joseph Nicolazzo, Andrew M Scott & Hui Kong Gan. (2021) Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?. Frontiers in Oncology 11.
Crossref
Javad Garousi, Haozhong Ding, Emma von Witting, Tianqi Xu, Anzhelika Vorobyeva, Maryam Oroujeni, Anna Orlova, Sophia Hober, Torbjörn Gräslund & Vladimir Tolmachev. (2021) Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein. Pharmaceutics 13:11, pages 1847.
Crossref
Asaminew H. Aytenfisu, Daniel Deredge, Erik H. Klontz, Jonathan Du, Eric J. Sundberg & Alexander D. MacKerell. (2021) Insights into substrate recognition and specificity for IgG by Endoglycosidase S2. PLOS Computational Biology 17:7, pages e1009103.
Crossref
Javad Garousi, Emma von Witting, Jesper Borin, Anzhelika Vorobyeva, Mohamed Altai, Olga Vorontsova, Mark W. Konijnenberg, Maryam Oroujeni, Anna Orlova, Vladimir Tolmachev & Sophia Hober. (2021) Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle. Biomaterials 266, pages 120381.
Crossref
Surendra Tripathy, Dilip Kumar Patel, Roohi Kesharwani & Malay K. Das. 2021. Multifunctional Theranostic Nanomedicines in Cancer. Multifunctional Theranostic Nanomedicines in Cancer 275 291 .
Ming Chen, Qiu-Ran Ma & Wan-Liang Lu. 2021. Liposome-Based Drug Delivery Systems. Liposome-Based Drug Delivery Systems 143 166 .
Eric Chabrol, Johann Stojko, Alexandre Nicolas, Thomas Botzanowski, Benjamin Fould, Mathias Antoine, Sarah Cianférani, Gilles Ferry & Jean A. Boutin. (2020) VHH characterization.Recombinant VHHs: Production, characterization and affinity. Analytical Biochemistry 589, pages 113491.
Crossref
Sagun Parakh, Dylan King, Hui K. Gan & Andrew M. Scott. 2020. Current Immunotherapeutic Strategies in Cancer. Current Immunotherapeutic Strategies in Cancer 1 70 .
Lawrence H. Cheung, Yunli Zhao, Ana Alvarez-Cienfuegos, Khalid A. Mohamedali, Yu J. Cao, Walter N. Hittelman & Michael G. Rosenblum. (2019) Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Sze Ting Lee, I. Burvenich & A.M. Scott. (2019) Novel Target Selection for Nuclear Medicine Studies. Seminars in Nuclear Medicine 49:5, pages 357-368.
Crossref
Ming Chen, Qiu-Ran Ma & Wan-Liang Lu. 2019. Liposome-Based Drug Delivery Systems. Liposome-Based Drug Delivery Systems 1 24 .
Andrew M. Scott, Yit Wooi Goh, Sze Ting Lee & Salvatore U. Berlangieri. 2019. Radiopharmaceutical Chemistry. Radiopharmaceutical Chemistry 541 553 .
Rijo John, Heero Vaswani, Prajakta Dandekar & Padma V. Devarajan. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis 45 78 .
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar & Yadollah Omidi. (2018) Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective. Journal of Molecular Medicine 96:9, pages 885-902.
Crossref
Asanka S. Yapa, Hongwang Wang, Sebastian O. Wendel, Tej. B. Shrestha, Nilusha L. Kariyawasam, Madumali Kalubowilage, Ayomi S. Perera, Marla Pyle, Matthew T. Basel, Aruni P. Malalasekera, Harshi Manawadu, Jing Yu, Yubisela Toledo, Raquel Ortega, Prem S. Thapa, Paul E. Smith, Deryl L. Troyer & Stefan H. Bossmann. (2018) Peptide nanosponges designed for rapid uptake by leukocytes and neural stem cells. RSC Advances 8:29, pages 16052-16060.
Crossref
Hui K. Gan, Martin van den Bent, Andrew B. Lassman, David A. Reardon & Andrew M. Scott. (2017) Antibody–drug conjugates in glioblastoma therapy: the right drugs to the right cells. Nature Reviews Clinical Oncology 14:11, pages 695-707.
Crossref
Sara Charmsaz, Andrew M. Scott & Andrew W. Boyd. (2017) Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors. Experimental Hematology 54, pages 31-39.
Crossref
Maria Daniela Garcia-Castillo, Daniel J.-F. Chinnapen & Wayne I. Lencer. (2017) Membrane Transport across Polarized Epithelia. Cold Spring Harbor Perspectives in Biology 9:9, pages a027912.
Crossref
S Charmsaz, F Al-Ejeh, T M Yeadon, K J Miller, F M Smith, B W Stringer, A S Moore, F-T Lee, L T Cooper, C Stylianou, G T Yarranton, J Woronicz, A M Scott, M Lackmann & A W Boyd. (2017) EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia. Leukemia 31:8, pages 1779-1787.
Crossref
Ricardo Titze-de-Almeida, Catherine David & Simoneide Souza Titze-de-Almeida. (2017) The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market. Pharmaceutical Research 34:7, pages 1339-1363.
Crossref
Jörgen Elgqvist. (2017) Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer. International Journal of Molecular Sciences 18:5, pages 1102.
Crossref
Ranjita Shegokar, Rajani Athawale, Nalini Kurup, Rongbing Yang & Mahavir B. Chougule. 2017. Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes. Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes 287 321 .
Alberto Grandi, Alice Santi, Susanna Campagnoli, Matteo Parri, Elisa De Camilli, Chaojun Song, Boquan Jin, Aurelien Lacombe, Serenella Castori-Eppenberger, Paolo Sarmientos, Guido Grandi, Giuseppe Viale, Luigi Terracciano, Paola Chiarugi, Piero Pileri & Renata Grifantini. (2016) ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer. Oncotarget 7:39, pages 63596-63610.
Crossref
Ketan Kulkarni. (2016) The continuing evolution of technology in cancer care. Future Oncology 12:17, pages 1961-1965.
Crossref
Adam Parslow, Sagun Parakh, Fook-Thean Lee, Hui Gan & Andrew Scott. (2016) Antibody–Drug Conjugates for Cancer Therapy. Biomedicines 4:3, pages 14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.